ASX-Dividend-Report-Banner

Frost & Sullivan Recognizes Innovaccer for Enabling Value-Based Care with Its AI and Advanced Analytics

February 13, 2024 12:00 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 Frost & Sullivan Recognizes Innovaccer for Enabling Value-Based Care with Its AI and Advanced Analytics
Image source: Kalkine Media

Innovaccer's AI-powered VBC solution suite unifies patient data seamlessly across diverse systems and care settings, empowering healthcare organizations with innovative, scalable applications.

SAN ANTONIO, Feb. 12, 2024 /PRNewswire/ -- After evaluating the revenue cycle management (RCM) industry, Frost & Sullivan announces that Innovaccer is the winner of the 2024 North American Technology Innovation Leadership Award for healthcare value-based care delivery excellence. Known for its innovative artificial intelligence (AI)-powered applications, the Innovaccer data platform provides the foundation for healthcare organizations to team members focus on high-value tasks and prioritize cases with the most significant impact on outcomes and revenue for resolution. While excelling in optimizing coding for VBC contracts, it distinguishes itself as a platform company that actively engages with healthcare ecosystem stakeholders.

The Innovaccer data platform establishes interoperability between healthcare IT systems, including legacy and mission-critical systems, to create a unified, longitudinal patient record. The platform also aggregates and cleans data from multiple sources, hydrates it to enable use in any application, activates it to integrate into workflows, and harmonizes it across relevant systems and care settings, ensuring it is synchronized.

Innovaccer offers a range of prescriptive and predictive analytics tools that are embedded in workflows to help value-based care organizations achieve a laser-sharp focus on improving risk coding and quality outcomes and reducing costs by prioritizing time and resources. The company's finance and contract management solutions help providers track and enhance revenue cycle performance for healthcare providers. It minimizes revenue loss, providing a comprehensive and efficient approach to managing claims and improving revenue integrity.

"As we experience unprecedented growth and innovation in healthcare, Innovaccer remains focused on developing game-changing technology solutions that address frontline point-of-care challenges. Receiving this award is a testament to our ongoing dedication to transforming the healthcare landscape," said Abhinav Shashank, cofounder and CEO of Innovaccer. "We are honored to be acknowledged by Frost & Sullivan, an esteemed authority in evaluating industry leaders. The 2024 North American Technology Innovation Leadership Award for value-based care delivery excellence is an affirmation of our commitment to improving risk management and reducing costs to enhance operating margins and improve patient outcomes through AI-powered workflows and advanced health data analytics."

Innovaccer's Sara for Healthcare, an innovative suite of AI solutions, was designed to help automate repetitive tasks, process medical information, uncover insights, and simplify access to data. Trained in healthcare context, the suite provides accurate, secure, and compliant solutions that reduce and automate workflows and support decisions, contributing to high-quality, low-cost, patient-centered care.

Dr. Rishi Pathak, global director of healthcare and life sciences at Frost & Sullivan, observed, "Innovaccer's unwavering commitment to customer-centricity is demonstrated through its tailored solutions that actively engage patients across their healthcare journey. With consistent 30% to 40% year-over-year growth, the company's multidimensional approach to data analytics and AI differentiates it as a comprehensive solution provider that improves patient care, streamlines workflows, and saves substantial costs for healthcare organizations."

Innovaccer's approach encompasses vital components in data analytics, population health, and more, establishing it as the preferred enterprise-focused company in the healthcare sector. It demonstrates an impressive commitment to innovation through its dynamic culture, strategic partnerships, and customer-centric practices dedicated to addressing healthcare challenges and delivering top-notch, patient-centered care. Additionally, Innovaccer's focus on bridging healthcare workforce challenges through advanced AI solutions underscores its commitment to enhancing efficiency and satisfaction in the industry, affirming its growth potential and impact in the evolving healthcare landscape.

"Innovaccer clearly distinguishes itself in the market through its dedication to innovation and creativity while achieving commercial success. It anticipates continued growth through its data platform, traditional value-based care platform adoption, value-based customer relationship management platform, and generative AI solutions addressing healthcare workforce challenges over the next five to ten years," added Ojaswi Rana, best practices research analyst at Frost & Sullivan. "With its strong overall performance, Innovaccer earned the 2024 Frost & Sullivan Technology Innovation Leadership Award in the healthcare revenue cycle management industry."

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables. Its best practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Contact:
Christine Savoie
E:[email protected]

About Innovaccer
Innovaccer Inc. is the data platform that accelerates care innovation. The Innovaccer platform unifies patient data across systems and care settings, and empowers healthcare organizations with scalable, modern applications that improve clinical, financial, operational, and experiential outcomes. Innovaccer's EHR-agnostic solutions have been deployed across more than 1,600 hospitals and clinics in the US, enabling care delivery transformation for more than 96,000 clinicians, and helping providers work collaboratively with payers and life sciences companies. Innovaccer has helped its customers unify health records for more than 54 million people and generate over $1.5 billion in cumulative cost savings. The Innovaccer platform is the #1 rated Best-in-KLAS data and analytics platform by KLAS, and the #1 rated population health technology platform by Black Book. For more information, please visit innovaccer.com.

Press Contact

Arushi Awasthi
Innovaccer Inc.
[email protected]
+91 9873359533


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.